Published in Cancers (Basel) on December 09, 2015
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet (1996) 26.06
Anemia of chronic disease. N Engl J Med (2005) 10.88
The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A (1998) 3.23
The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem (1997) 2.62
Tobacco, oral cancer, and treatment of dependence. Oral Oncol (2005) 2.13
Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr (1974) 2.06
Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci U S A (1997) 2.03
Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls. Hepatology (2007) 1.94
Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet (2000) 1.89
Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer. J Natl Cancer Inst (2003) 1.80
Regulation of iron acquisition and iron distribution in mammals. Biochim Biophys Acta (2006) 1.72
Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg (2006) 1.71
Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions. Cancer Res (1985) 1.58
Plummer-Vinson syndrome. Orphanet J Rare Dis (2006) 1.52
Gender differences in smoking and risk for oral cancer. Cancer Res (1996) 1.47
Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA (2001) 1.33
An evaluation of adsorption methods for measurement of plasma iron-binding capacity. J Lab Clin Med (1970) 1.33
Oral cavity and pharynx cancer incidence rates in the United States, 1975-1998. Oral Oncol (2002) 1.27
Risk factors for oral cancer in Brazil: a case-control study. Int J Cancer (1989) 1.24
Diet and nutrition in the etiology of oral cancer. Am J Clin Nutr (1995) 1.23
The regulation of cellular iron metabolism. Crit Rev Clin Lab Sci (2007) 1.21
Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3. J Gastroenterol Hepatol (2001) 1.17
Epidemiology of squamous cell cancer of the head and neck. Otolaryngol Clin North Am (1985) 1.07
Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants. Ann Hematol (2009) 1.00
Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy. J Hepatol (2001) 0.99
Hepatic iron overload and hepatocellular carcinoma. Cancer Lett (2008) 0.98
Evaluation of the association studies of single nucleotide polymorphisms and hepatocellular carcinoma: a systematic review. J Cancer Res Clin Oncol (2011) 0.98
H63D is an haemochromatosis associated allele. Gut (1998) 0.97
Factors influencing disease phenotype and penetrance in HFE haemochromatosis. Hum Genet (2010) 0.97
Iron and ferritin in inflammation and cancer. Adv Inorg Biochem (1994) 0.95
Blood iron, glutathione, and micronutrient levels and the risk of oral cancer. Nutr Cancer (2008) 0.93
Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 0.93
Mutations of the HFE gene in patients with hepatocellular carcinoma. Am J Gastroenterol (2003) 0.91
Spectrophotometric plasma iron determination from fingerpuncture specimens. Clin Chim Acta (1979) 0.91
Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities. Protein Cell (2014) 0.91
No evidence of increased risk of colorectal cancer in individuals heterozygous for the Cys282Tyr haemochromatosis mutation. J Gastroenterol Hepatol (1999) 0.90
Association between C282Y and H63D mutations of the HFE gene with hepatocellular carcinoma in European populations: a meta-analysis. J Exp Clin Cancer Res (2010) 0.90
Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk. Cancer (2003) 0.90
Heterozygosity for the Cys282Tyr mutation in the HFE gene and the risk of colorectal cancer (Netherlands). Cancer Causes Control (2003) 0.89
Frequency of hemochromatosis gene (HFE) mutations in Russian healthy women and patients with estrogen-dependent cancers. Biochim Biophys Acta (2005) 0.89
HFE H63D mutation frequency shows an increase in Turkish women with breast cancer. BMC Cancer (2006) 0.87
Evidence for an association between compound heterozygosity for germ line mutations in the hemochromatosis (HFE) gene and increased risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2005) 0.87
HFE C282Y and H63D in adults with malignancies in a community medical oncology practice. BMC Cancer (2004) 0.85
Colorectal cancer and HFE gene mutations. Haematologica (1999) 0.85
Etiological and preventive implications in alcohol carcinogenesis. Cancer Res (1979) 0.84
High frequency of the H63D mutation of the hemochromatosis gene (HFE) in malignant gliomas. Neurology (2001) 0.84
Tobacco, antioxidant enzymes, oxidative stress, and genetic susceptibility in oral cancer. Am J Clin Oncol (2008) 0.83
HFE gene C282Y variant is associated with colorectal cancer in Caucasians: a meta-analysis. Tumour Biol (2013) 0.83
Clinical penetrance of C282Y homozygous HFE hemochromatosis. Expert Rev Hematol (2008) 0.82
Nutrition and oral cancer. Cancer Causes Control (1996) 0.82
The C282Y mutation of HFE is another male-specific risk factor for childhood acute lymphoblastic leukemia. Blood (1999) 0.82
Hemochromatosis (HFE) gene mutations and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Carcinogenesis (2013) 0.81
Prevalence of hemochromatosis related HFE gene mutations in patients with acute myeloid leukemia. Leuk Res (1999) 0.79
Prevalence and clinical significance of HFE gene mutations in patients with iron overload. Am J Gastroenterol (2000) 0.79
Epistasis of oxidative stress-related enzyme genes on modulating the risks in oral cavity cancer. Clin Chim Acta (2010) 0.79
Haemochromatosis gene (HFE) mutations in viral-associated neoplasia: Linkage to cervical cancer. Biochem Biophys Res Commun (2006) 0.79
Clinical consult: iron overload--hereditary hemochromatosis. Prim Care (2004) 0.78
High incidence of extrahepatic carcinomas in idiopathic hemochromatosis. Scand J Gastroenterol (1980) 0.78
Iron toxicity and its possible association with treatment of Cancer: lessons from hemoglobinopathies and rare, transfusion-dependent anemias. Free Radic Biol Med (2014) 0.76